These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 37182594
1. An allosteric modulator of the adenosine A1 receptor potentiates the antilipolytic effect in rat adipose tissue. Fu K, Chen W, Meng M, Zhao H, Yuan H, Wang Y, Ren Y, Yun Y, Guo D. Eur J Pharmacol; 2023 Jul 15; 951():175777. PubMed ID: 37182594 [Abstract] [Full Text] [Related]
2. Differential effects of the allosteric enhancer (2-amino-4,5-dimethyl-trienyl)[3-trifluoromethyl) phenyl]methanone (PD81,723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A1 receptor. Kourounakis A, Visser C, de Groote M, IJzerman AP. Biochem Pharmacol; 2001 Jan 15; 61(2):137-44. PubMed ID: 11163328 [Abstract] [Full Text] [Related]
3. The allosteric enhancer PD81,723 increases chimaeric A1/A2A adenosine receptor coupling with Gs. Bhattacharya S, Youkey RL, Ghartey K, Leonard M, Linden J, Tucker AL. Biochem J; 2006 May 15; 396(1):139-46. PubMed ID: 16390330 [Abstract] [Full Text] [Related]
4. Probe dependence of allosteric enhancers on the binding affinity of adenosine A1 -receptor agonists at rat and human A1 -receptors measured using NanoBRET. Cooper SL, Soave M, Jörg M, Scammells PJ, Woolard J, Hill SJ. Br J Pharmacol; 2019 Apr 15; 176(7):864-878. PubMed ID: 30644086 [Abstract] [Full Text] [Related]
15. Effects of the adenosine A1 receptor allosteric modulators PD 81,723 and LUF 5484 on the striatal acetylcholine release. Bueters TJ, van Helden HP, Danhof M, IJzerman AP. Eur J Pharmacol; 2002 Nov 15; 454(2-3):177-82. PubMed ID: 12421644 [Abstract] [Full Text] [Related]
16. Anticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain. Concas A, Santoro G, Mascia MP, Maciocco E, Dazzi L, Ongini E, Biggio G. J Pharmacol Exp Ther; 1993 Nov 15; 267(2):844-51. PubMed ID: 8246158 [Abstract] [Full Text] [Related]
18. Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety. Vincenzi F, Ravani A, Pasquini S, Merighi S, Gessi S, Romagnoli R, Baraldi PG, Borea PA, Varani K. Neuropharmacology; 2016 Dec 15; 111():283-292. PubMed ID: 27639989 [Abstract] [Full Text] [Related]
19. Comparison of the antilipolytic effects of an A1 adenosine receptor partial agonist in normal and diabetic rats. Dhalla AK, Santikul M, Chisholm JW, Belardinelli L, Reaven GM. Diabetes Obes Metab; 2009 Feb 15; 11(2):95-101. PubMed ID: 18494808 [Abstract] [Full Text] [Related]
20. The effect of allosteric modulators on the kinetics of agonist-G protein-coupled receptor interactions in single living cells. May LT, Self TJ, Briddon SJ, Hill SJ. Mol Pharmacol; 2010 Sep 15; 78(3):511-23. PubMed ID: 20571079 [Abstract] [Full Text] [Related] Page: [Next] [New Search]